177 related articles for article (PubMed ID: 3057399)
1. Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study.
Brodeur C; Montplaisir J; Godbout R; Marinier R
Neurology; 1988 Dec; 38(12):1845-8. PubMed ID: 3057399
[TBL] [Abstract][Full Text] [Related]
2. Restless legs syndrome and periodic movements in sleep: physiopathology and treatment with L-dopa.
Montplaisir J; Godbout R; Poirier G; Bédard MA
Clin Neuropharmacol; 1986; 9(5):456-63. PubMed ID: 3021323
[TBL] [Abstract][Full Text] [Related]
3. A controlled study of additional sr-L-dopa in L-dopa-responsive restless legs syndrome with late-night symptoms.
Collado-Seidel V; Kazenwadel J; Wetter TC; Kohnen R; Winkelmann J; Selzer R; Oertel WH; Trenkwalder C
Neurology; 1999 Jan; 52(2):285-90. PubMed ID: 9932945
[TBL] [Abstract][Full Text] [Related]
4. L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial.
Trenkwalder C; Stiasny K; Pollmächer T; Wetter T; Schwarz J; Kohnen R; Kazenwadel J; Krüger HP; Ramm S; Künzel M
Sleep; 1995 Oct; 18(8):681-8. PubMed ID: 8560135
[TBL] [Abstract][Full Text] [Related]
5. Acute double-blind, placebo-controlled sleep laboratory and clinical follow-up studies with a combination treatment of rr-L-dopa and sr-L-dopa in restless legs syndrome.
Saletu M; Anderer P; Högl B; Saletu-Zyhlarz G; Kunz A; Poewe W; Saletu B
J Neural Transm (Vienna); 2003 Jun; 110(6):611-26. PubMed ID: 12768357
[TBL] [Abstract][Full Text] [Related]
6. Treatment of periodic leg movements with a dopaminergic agonist in subjects with total spinal cord lesions.
de Mello MT; Poyares DL; Tufik S
Spinal Cord; 1999 Sep; 37(9):634-7. PubMed ID: 10490854
[TBL] [Abstract][Full Text] [Related]
7. L-Dopa improves Restless Legs Syndrome and periodic limb movements in sleep but not Attention-Deficit-Hyperactivity Disorder in a double-blind trial in children.
England SJ; Picchietti DL; Couvadelli BV; Fisher BC; Siddiqui F; Wagner ML; Hening WA; Lewin D; Winnie G; Cohen B; Walters AS
Sleep Med; 2011 May; 12(5):471-7. PubMed ID: 21463967
[TBL] [Abstract][Full Text] [Related]
8. L-DOPA/carbidopa for nocturnal movement disorders in uremia.
Walker SL; Fine A; Kryger MH
Sleep; 1996 Apr; 19(3):214-8. PubMed ID: 8723378
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of idiopathic and uremic restless legs syndrome with L-dopa--a double-blind cross-over study].
Wetter TC; Trenkwalder C; Stiasny K; Pollmächer T; Kazenwadel J; Kohnen R; Künzel M; Oertel WH
Wien Med Wochenschr; 1995; 145(17-18):525-7. PubMed ID: 8588396
[TBL] [Abstract][Full Text] [Related]
10. Rapid onset of action of levodopa in restless legs syndrome: a double-blind, randomized, multicenter, crossover trial.
Benes H; Kurella B; Kummer J; Kazenwadel J; Selzer R; Kohnen R
Sleep; 1999 Dec; 22(8):1073-81. PubMed ID: 10617168
[TBL] [Abstract][Full Text] [Related]
11. Pergolide: treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS). A double-blind randomized crossover trial of pergolide versus L-Dopa.
Staedt J; Wassmuth F; Ziemann U; Hajak G; Rüther E; Stoppe G
J Neural Transm (Vienna); 1997; 104(4-5):461-8. PubMed ID: 9295178
[TBL] [Abstract][Full Text] [Related]
12. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
Fulda S; Wetter TC
Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
[TBL] [Abstract][Full Text] [Related]
13. One-year treatment with standard and sustained-release levodopa: appropriate long-term treatment of restless legs syndrome?
Trenkwalder C; Collado Seidel V; Kazenwadel J; Wetter TC; Oertel W; Selzer R; Kohnen R
Mov Disord; 2003 Oct; 18(10):1184-9. PubMed ID: 14534925
[TBL] [Abstract][Full Text] [Related]
14. Effect of Gabapentin Enacarbil on Individual Items of the International Restless Legs Study Group Rating Scale and Post-sleep Questionnaire in Adults with Moderate-to-Severe Primary Restless Legs Syndrome: Pooled Analysis of 3 Randomized Trials.
Ahmed M; Hays R; Steven Poceta J; Jaros MJ; Kim R; Shang G
Clin Ther; 2016 Jul; 38(7):1726-1737.e1. PubMed ID: 27288210
[TBL] [Abstract][Full Text] [Related]
15. Leg movements during wakefulness in restless legs syndrome: time structure and relationships with periodic leg movements during sleep.
Ferri R; Manconi M; Plazzi G; Bruni O; Cosentino FI; Ferini-Strambi L; Zucconi M
Sleep Med; 2012 May; 13(5):529-35. PubMed ID: 22341907
[TBL] [Abstract][Full Text] [Related]
16. Restless legs syndrome treatment with dopaminergic drugs.
Akpinar S
Clin Neuropharmacol; 1987; 10(1):69-79. PubMed ID: 3545461
[TBL] [Abstract][Full Text] [Related]
17. Treatment of idiopathic restless legs syndrome (RLS) with slow-release valproic acid compared with slow-release levodopa/benserazid.
Eisensehr I; Ehrenberg BL; Rogge Solti S; Noachtar S
J Neurol; 2004 May; 251(5):579-83. PubMed ID: 15164191
[TBL] [Abstract][Full Text] [Related]
18. Persistence of repetitive EEG arousals (K-alpha complexes) in RLS patients treated with L-DOPA.
Montplaisir J; Boucher S; Gosselin A; Poirier G; Lavigne G
Sleep; 1996 Apr; 19(3):196-9. PubMed ID: 8723375
[TBL] [Abstract][Full Text] [Related]
19. Pramipexole versus dual release levodopa in restless legs syndrome: a double blind, randomised, cross-over trial.
Bassetti CL; Bornatico F; Fuhr P; Schwander J; Kallweit U; Mathis J;
Swiss Med Wkly; 2011; 141():w13274. PubMed ID: 22101745
[TBL] [Abstract][Full Text] [Related]
20. Night-to-night variability of periodic leg movements during sleep in restless legs syndrome and periodic limb movement disorder: comparison between the periodicity index and the PLMS index.
Ferri R; Fulda S; Manconi M; Högl B; Ehrmann L; Ferini-Strambi L; Zucconi M
Sleep Med; 2013 Mar; 14(3):293-6. PubMed ID: 23068780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
